Sutro Biopharma, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of STRO for the last quarter is 25.71 M USD, and it's 97.62% higher compared to the previous quarter. The net income of Q2 24 is -48.02 M USD.